We are live on ! Find out more
PCIA

Prime Capital Investment Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 25.54%
This Fund
S&P 500
This Quarter Est. Return
+7.41%
1 Year Est. Return
+25.54%
3 Year Est. Return
+71.27%
5 Year Est. Return
+71.75%
10 Year Est. Return
AUM
$7.97B
AUM Growth
+$435M
Cap. Flow
-$48M
Cap. Flow %
-0.6%
Top 10 Hldgs %
28.54%
Holding
1,070
New
110
Increased
428
Reduced
443
Closed
38

Sector Composition

Rank Sector Weight
1 Technology 13.16%
2 Financials 4.41%
3 Consumer Discretionary 3.63%
4 Industrials 3.34%
5 Communication Services 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JOBY icon
951
Joby Aviation
JOBY
$8.17B
$200K ﹤0.01%
+12,387
New +$188K
FLO icon
952
Flowers Foods
FLO
$1.6B
$198K ﹤0.01%
15,192
+1,615
+12% +$24.5K
LYG icon
953
Lloyds Banking Group
LYG
$90B
$194K ﹤0.01%
42,739
+2,535
+6% +$11.1K
OWL icon
954
Blue Owl Capital
OWL
$19.7B
$194K ﹤0.01%
+11,451
New +$218K
FNB icon
955
FNB Corp
FNB
$6.88B
$193K ﹤0.01%
11,966
PDT
956
John Hancock Premium Dividend Fund
PDT
$628M
$191K ﹤0.01%
14,330
+41
+0.3% +$547
GNL icon
957
Global Net Lease
GNL
$1.9B
$190K ﹤0.01%
23,326
-496
-2% -$3.79K
AVGO icon
958
CALL
Broadcom
AVGO
$1.99T
$164K ﹤0.01%
+3,000
New +$920K
NUV icon
959
Nuveen Municipal Value Fund
NUV
$1.9B
$157K ﹤0.01%
17,484
-2,032
-10% -$17.7K
GAIN icon
960
Gladstone Investment Corp
GAIN
$658M
$148K ﹤0.01%
+10,730
New +$151K
LEG icon
961
Leggett & Platt
LEG
$1.32B
$134K ﹤0.01%
15,109
-423
-3% -$4.03K
RXRX icon
962
Recursion Pharmaceuticals
RXRX
$1.78B
$134K ﹤0.01%
27,403
-2,943
-10% -$15.5K
UMC icon
963
United Microelectronic
UMC
$48.6B
$129K ﹤0.01%
16,990
+2,741
+19% +$19.4K
VTRS icon
964
Viatris
VTRS
$18.4B
$128K ﹤0.01%
12,880
+87
+0.7% +$847
NOK icon
965
Nokia
NOK
$59B
$125K ﹤0.01%
26,022
+1,848
+8% +$8.35K
CIG icon
966
CEMIG Preferred Shares
CIG
$5.58B
$123K ﹤0.01%
58,324
+6,335
+12% +$12.4K
BFZ
967
DELISTED
BlackRock CA Municipal Income Trust
BFZ
$110K ﹤0.01%
10,000
META icon
968
CALL
Meta Platforms (Facebook)
META
$1.52T
$107K ﹤0.01%
+2,000
New +$1.49M
EDIT icon
969
Editas Medicine
EDIT
$432M
$101K ﹤0.01%
29,219
-3,039
-9% -$8.48K
DMA
970
Destra Multi-Alternative Fund
DMA
$69.4M
$99.5K ﹤0.01%
11,512
MPT
971
Medical Properties Trust
MPT
$2.51B
$98.1K ﹤0.01%
19,358
-4,377
-18% -$19.3K
LUMN icon
972
Lumen
LUMN
$6.6B
$95.1K ﹤0.01%
15,541
+74
+0.5% +$355
HUN icon
973
Huntsman Corp
HUN
$1.81B
$91.7K ﹤0.01%
+10,208
New +$107K
CRBU icon
974
Caribou Biosciences
CRBU
$160M
$80.8K ﹤0.01%
34,674
-3,319
-9% -$6.27K
PRME icon
975
Prime Medicine
PRME
$575M
$79.7K ﹤0.01%
14,379
-1,652
-10% -$6.71K

Similar funds

Prime Capital Investment Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Prime Capital Investment Advisors held 1,070 positions worth $7.97B, up 5.8% from $7.53B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Prime Capital Investment Advisors's Q3 2025 filing shows 110 new, 428 increased, 443 reduced and 38 closed positions. Its largest new stake was Aptus Deferred Income ETF: 54,897 shares worth $1.44M. The largest sale was Carlyle Secured Lending, an estimated $30.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Prime Capital Investment Advisors's largest Q3 2025 buy was Aptus Deferred Income ETF: 54,897 shares worth $1.44M.
  • Prime Capital Investment Advisors added most to iShares Core US Aggregate Bond ETF in Q3 2025, an estimated $21.2M increase.
  • Prime Capital Investment Advisors's biggest Q3 2025 reduction was Schwab US Large- Cap ETF, cutting an estimated $23.1M.
  • Prime Capital Investment Advisors fully exited Carlyle Secured Lending in Q3 2025, selling an estimated $30.2M.
  • Prime Capital Investment Advisors's ten largest holdings make up 29% of its $7.97B portfolio in Q3 2025.
  • Prime Capital Investment Advisors opened 110 new positions and closed 38 in Q3 2025.
  • Prime Capital Investment Advisors's portfolio value rose 5.8% quarter-over-quarter to $7.97B.

Based on Prime Capital Investment Advisors's 13F filing for Q3 2025, filed 5 Nov 2025.